Showing results (141-150 of 662) with videos related to
Sort By:
Pageof 67
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storageD L Kukis, S J DeNardo, S L Mills, et al.Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Impact of interpatient pharmacokinetic variability on design considerations for therapy with radiolabeled MAbsGerald DeNardo, Aina Yuan, Desiree Goldstein, et al.Hybridoma|January 1, 1986
123I radiolabeling of monoclonal antibodies for in vivo proceduresS L Mills, S J Denardo, G L Denardo, et al.Nuclear Medicine and Biology|January 11, 2000
Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patientsG R Mirick, R T O'Donnell, S J DeNardo, et al.Cancer Research|August 3, 2002
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenograftsPatricia A Burke, Sally J DeNardo, Laird A Miers, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Prolonged survival associated with immune response in a patient treated with Lym-1 mouse monoclonal antibodyS J DeNardo, L A Kroger, M R MacKenzie, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Determination of spleen size by scintigraphyS Silverman, G L DeNardo, E SiegelPhysiological and Biochemical Zoology : PBZ|February 26, 2013
Structural and performance costs of reproduction in a pure capital breeder, the Children's python Antaresia childreniOlivier Lourdais, Sophie Lorioux, Dale F DeNardoBioconjugate Chemistry|June 4, 2008
NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokineticsA Natarajan, C Gruettner, R Ivkov, et al.The Journal of Clinical Investigation|November 1, 1980
Noninvasive measurement of pulmonary transvascular protein flux in normal manA B Gorin, J Kohler, G DeNardoPageof 67